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Abstract
Background: The lifetime testicular cancer (TC) risk in the general population is relatively low
(~1 in 250), but men with a family history of TC are at 4 to 9 times greater risk than those without.
Some health and professional organizations recommend consideration of testicular self-
examination (TSE) for certain high-risk groups (e.g. men with a family history of TC). Yet little is
known about factors associated with TSE behaviors in this at-risk group.
Methods: We collected information on this subject during an on-going NCI multidisciplinary,
etiologically-focused, cross-sectional Familial Testicular Cancer (FTC) study. We present the first
report specifically targeting TSE behaviors among first- and second-degree relatives (n = 99) of
affected men from families with ≥ 2 TC cases. Demographic, medical, knowledge, health belief, and
psychological factors consistent with the Health Belief Model (HBM) were evaluated as variables
related to TSE behavior, using chi-square tests of association for categorical variables, and t-tests
for continuous variables.
Results: For men in our sample, 46% (n = 46) reported performing TSE regularly and 51% (n =
50) reported not regularly performing TSE. Factors associated (p < .05) with regularly performing
TSE in multivariate analysis were physician recommendation and testicular cancer worry. This is
the first study to examine TSE in unaffected men from FTC families.
Conclusion: The findings suggest that, even in this high-risk setting, TSE practices are sub-optimal.
Our data provide a basis for further exploring psychosocial issues that are specific to men with a
family history of TC, and formulating intervention strategies aimed at improving adherence to TSE
guidelines.
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Introduction
Although testicular cancer (TC) accounts for only 1% of
all male cancers, it is the most common cancer in younger
men aged 20–35 years old, with about 8,090 new cases
estimated to occur during 2008 in the U.S. [1]. TC inci-
dence rates have been rising since the mid-twentieth cen-
tury, especially among white males [2], while the rates of
many other cancers have been decreasing. Although 5-
year survival for TC has increased over the past several dec-
ades, long term survival remains related to stage at diag-
nosis [3], with localized TC 5-year survival rates of 99.5%,
versus 70.1% for metastatic TC [4]. In addition, earlier
stage disease often requires less extensive treatment. Thus,
early detection may minimize both TC-associated mor-
bidity and mortality [5-7].
Leading health organizations debate the efficacy of testic-
ular self-examination (TSE) in reducing TC related mortal-
ity [8], particularly with the advent of chemotherapeutic
regimens that are highly-effective even for men with
advanced disease during the last several decades. How-
ever, this decrease in mortality is accompanied by an
increase in treatment-related morbidity, particularly for
those cancers that are diagnosed at later stages [6,9]. A
recent review found little shift of the approximate 5-
month delay from onset of TC symptoms to surgical diag-
nosis over the past seventy-five years [10]. While TSE may
not markedly improve the already high survival rates
related to TC, early diagnosis does bring significant poten-
tial to reduce treatment-related morbidity, since surgery
plus close surveillance is a viable management option for
many early-stage patients [10]. Education and instruction
for men on the normal shape and texture of the testicles,
plus information regarding signs and symptoms associ-
ated with TC could be a critical component in reducing
treatment delay [11,12].
Additionally, as epidemiological research identifies spe-
cific TC risk factors, some organizations have refined their
screening recommendations to focus on high-risk groups.
Established TC risk factors include cryptorchidism (unde-
scended testes), prior contralateral TC and testicular intra-
epithelial neoplasia. Testicular cancer risk is also increased
in certain genetic conditions, such as Klinefelter and
androgen insensitivity syndromes. Other conditions that
may increase TC risk include urogenital malformations,
testicular dysgenesis, testicular atrophy, history of infertil-
ity, and, possibly, exposures to a variety of etiologic agents
during key developmental periods [13]. Perhaps most
importantly, family history is known to be an important
independent risk factor. Approximately 1–3% of men
with testicular cancer report the presence of another
affected male in their family. Sons of men with TC have a
four- to six-fold increase in risk of TC, and brothers carry
an eight- to ten-fold increase in the risk when compared
with the general population [14-16].
The American Cancer Society recommends that men with
known risk factors such as family history seriously con-
sider performing TSE regularly. This approach to modify-
ing general population early cancer detection practices for
high-risk populations is not unique to men with a familial
risk for TC. For example, the National Comprehensive
Cancer Network recommends routine breast self-exami-
nation (BSE) for women at increased risk of hereditary
breast and ovarian cancer (HBOC) [17], despite rand-
omized controlled trial data refuting the efficacy of BSE in
reducing breast cancer mortality [18]. In addition to the
possibility that TSE recommendations for self-examina-
tion may reduce chemotherapy-related morbidity by
increasing the proportion of early-stage TC diagnosed in
high-risk men, there may also be further benefit in provid-
ing at-risk individuals with a management strategy that
involves them directly in their own care, and gives them
an enhanced sense of control over their lives [10].
While TSE practices among general population young
males have been extensively studied [2,19-26], there are
no published data specific to TSE practices among multi-
ple-case family members.
We present an analysis of data collected from participants
in a National Cancer Institute (NCI) multidisciplinary,
etiologically-focused study of familial testicular cancer
(FTC). Its primary aims include [1] identifying FTC sus-
ceptibility genes; [2] characterizing the FTC syndrome
clinical phenotype; and [3] evaluating psychosocial and
behavioral issues resulting from being a member of a fam-
ily at increased risk of testicular germ cell tumor (TGCT).
Segregation analysis has suggested that an autosomal
recessive genetic model best explains the distribution of
disease in FTC families although, to date, no specific TC
susceptibility genes have been identified [27]. The current
exploratory sub-study describes the TSE practices of unaf-
fected at-risk men from multiple-case families, and char-
acterizes key demographic, medical, knowledge, health
belief, and psychological factors associated with TSE using
Health Belief Model (HBM) constructs and terminology
[28]. Specifically, we included the HBM variables of per-
ceived benefits, barriers, susceptibility and severity. As
previously discussed, TSE may improve high-risk men's
sense of control over their own health [10,29]. Thus, to
examine this association we assessed health locus of con-
trol. Finally, previous behavioral research has emphasized
the role of affect in health behaviors [30], thus we
included the psychological variables of cancer worry and
distress.Hereditary Cancer in Clinical Practice 2009, 7:11 http://www.hccpjournal.com/content/7/1/11
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Materials and methods
Study Population
The 99 TSE sub-study participants were members of 47
families enrolled on an NCI Clinical Genetics Branch
(CGB) IRB-approved protocol (#02-C-0178) [31]. Fami-
lies were eligible for the main study if they had ≥ 2 con-
firmed cases of TC, or a single family member with
bilateral TC. Eligible individuals included all TC cases age
> 12 years, their first- and second-degree relatives), and
blood relatives who either linked the two TC cases or who
had themselves been diagnosed with cancer other than
TC. In addition, spouses were included if they had chil-
dren ≥ 12 years old who were study participants. Partici-
pants were ascertained through multiple referral
mechanisms: 62/99 (63%) from healthcare providers
(primarily physicians and genetic counselors), in
response to mailed recruitment letters; 15/99 (15%) from
the Testicular Cancer Resource Center (TCRC) http://
tcrc.acor.org/, a patient advocacy group,; 13/99 (13%)
self-referred through our study website http://familial-tes
ticular-cancer.cancer.gov; and 9/99 (10%) from other
sources. Unaffected males > age18 who were first- or sec-
ond-degree relatives of a TC case were included in the cur-
rent TSE analysis.
Data Collection
Data were collected via a mailed, written questionnaire
(the Lifestyle and Attitudes Questionnaire [LAQ]), devel-
oped specifically for the FTC study. The present analysis
was limited to those LAQ items pertaining to TSE and the
relevant independent variables. These independent varia-
bles included items and scale scores from standardized,
validated psychometric instruments, as well as items
developed specifically for this study.
Measures
For this analysis, we chose variables of theoretical and
practical interest related to predicting health behavior, as
well as other factors which have been previously-impli-
cated as related to cancer self-examination behavior.
Demographic and Medical Characteristics
Various sociodemographic and medical characteristics
were assessed via  self-report questionnaire: The age
dichotomy (< 35; > 35) was selected based on ages of men
at greatest TC risk; race (white; other); marital status
(divorced/single/unknown; married); education (< high
school; at least some college; post- graduate); relation to a
TC case (first-degree relative; second-degree relative); and
prior history of testicular abnormality (cryptorchidism,
orchitis, epididymitis, or injury to testicle; no abnormali-
ties).
Knowledge of TC
We measured knowledge regarding TC with the Testicular
Cancer Knowledge Scale (TCKS), a 10-item scale (range of
scores = 0–10 determined by the sum of questions
answered correctly) based on an instrument developed to
assess TC-related knowledge among young adults (Cron-
bach's alpha = .70) [20], including items regarding TC eti-
ology, the timing and method of TSE, and the sequelae of
TC. Each item had 3 possible answers: Agree, Disagree, or
Don't Know.
Health Belief Model Variables
We evaluated critical HBM concepts: perceived TC suscep-
tibility and severity, as well as perceived benefits and bar-
riers to TSE. In keeping with more recent HBM
applications [32,33], we included the Cue to Action con-
struct. We also included the health locus of control con-
cept to assess individual belief that health is controlled by
internal or external factors, such as performing self-exam-
inations for cancer.
Perceived Susceptibility to Testicular Cancer Scale
Perceived susceptibility was assessed using previously-val-
idated items associated with developing testicular [19]
and breast cancer [34]. Perception of TC susceptibility was
measured by summing responses to 3 five-point Likert
scale items (1 = strongly agree to 5 = strongly disagree)
(Cronbach's alpha = 0.76). An example of an item from
this scale: "It is likely that I will get testicular cancer."
Perceived Severity of Testicular Cancer Scale
Perceived severity was assessed using previously-validated
items associated with developing testicular cancer [19].
However, due to the low Cronbach's alpha for this scale in
our sample [40], we included each item as a separate var-
iable in the bivariate analyses. Thus, perception of severity
was measured using individual values of three items with
a five-point Likert scale (1 = strongly agree to 5 = strongly
disagree). An example of an item from this scale: "If I got
testicular cancer, its impact on my life would be severe."
Perceived Benefits of Testicular Self-examination
Perceived benefits were assessed using responses to 6 five-
point Likert scale items (1 = strongly agree to 5 = strongly
disagree) derived from previous health beliefs research
regarding testicular [19] and breast cancer [34] risk (Cron-
bach's alpha = 0.77). An example of an item from this
scale: "If I examined my own testicles regularly, I might find a
lump sooner that if I just went to the doctor for a check up."
Perceived Barriers
Perceived barriers were assessed using responses to 7 five-
point Likert scale items (1 = strongly agree to 5 = strongly
disagree) derived from previous health beliefs research
regarding testicular [19] and breast cancer risk [34] (Cron-Hereditary Cancer in Clinical Practice 2009, 7:11 http://www.hccpjournal.com/content/7/1/11
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bach alpha = 0.61).). An example of an item from this
scale: "I am too busy to do TSE."
Cue to Action for TSE
Previous cancer prevention behavior studies identified
physician recommendation as a key factor predicting
uptake of cancer self-examination behaviors. We adapted
a single 2000 National Health Interview Survey item to
assess whether a physician had ever recommended per-
forming TSE (yes, no).
Locus of Control
The Multidimensional Health Locus of Control (MHLC)
Scale consists of 3 six-point Likert scales (total: 18 items)
(1 = strongly agree to 6 = strongly disagree). Internal
Health Locus of Control (IHLC) quantifies the belief that
internal factors are responsible for health/illness (Cron-
bach's alpha = .78); Powerful Others Health Locus of Con-
trol (PHLC) quantifies the belief that one's health is
determined by powerful others (Cronbach's alpha = .57);
and Chance Health Locus of Control (CHLC) quantifies
the belief that health illness is a matter of fate, luck or
chance (Cronbach's alpha = .62). [35]
Psychological Variables
We measured cancer worry and cancer distress (intrusive
and avoidant thoughts).
Cancer Worry
We modified the Lerman Breast Cancer Worry Scale to
assess cancer worry among men at risk of TC [36]. The
scale assesses frequency of concerns about developing tes-
ticular cancer and the impact of cancer worry on mood
and daily functioning on a 4-point scale (1 = not at all or
rarely, to 4 = a lot) (Cronbach's alpha = 0.82) [36].
Cancer Distress via the Impact of Events Scale (IES)
The IES [37] measures the subjective impact of a specific
event on an individual by assessing two major responses
to stressful events: intrusion and avoidance. Intrusion is
characterized by repetitive thoughts, mental images, dis-
turbing dreams, and repetitive behavior, and is scored
from 0 – 35 (Cronbach's alpha = .90). Avoidance is asso-
ciated with denial of consequences from an event, blunted
feelings, and emotional numbness related to an event
[37], and is scored from 0 – 40 (Cronbach's alpha = .90).
Respondents used a 4-point response scale (0 = 'not at all',
1 = 'rarely', 3 = 'sometimes', 5 = 'often') from a set of 15
TC-related statements to report the frequency with respect
with which each occurred during the prior 7 days. It is a
reliable and valid instrument for cancer-related distress
among men and women either affected by or at risk of var-
ious cancers [38].
Practice of TSE
This was the primary analysis outcome. In the question-
naire, TSE was described as follows: "Testicular Self-exami-
nation (TSE) is when a man checks himself for any
abnormalities in his testicles." Participants were then asked
to provide a numerical response to the question "Have
many times during the past year have you performed TSE?".
We then classified men into two groups: those who regu-
larly performed TSE (≥ 6 times in the past year) and those
who did not regularly perform TSE (0–5 times in the
past year). Previously- published research on TSE practices
has used various standards to classify an individual as a
regular performer of TSE, ranging from simply asking an
individual whether they regularly perform TSE (yes, no)
without defining the term "regular" [39], to categories
based on a numeric response to a question about the fre-
quency of TSE in a specified time frame [19,26]. However,
the cut points for categorizing an individual as a regular
TSE performer differ among studies. For example, one
study considered an individual who reported performing
TSE 1 to 10 times a year as a regular performer [26], while
another considered only individuals who reported prac-
ticing TSE 12 times in the previous year as a regular per-
former [19]. There is current a lack of consensus among
leading health and professional organizations on the rec-
ommended interval for TSE screening, and a lack of con-
sistency in research studies regarding who is considered to
be a "regular performer." Thus, we opted for a moderate
approach whereby individuals who reported TSE > 6
times in the previous year were classified as regular per-
formers, and those who reported TSE < 6 times as non-reg-
ular performers of TSE.
Data Analysis
The main outcome of interest was Practice of TSE, a
dichotomous variable consisting of those who reported
they had regularly performed TSE (> 6 times in the previ-
ous year) compared to those who did not (< 6 times in the
previous year). Descriptive statistics and reliability analy-
ses were performed using the SPSS v. 15.0 statistical soft-
ware package, and multivariate logistic regression
employed SAS version 9.1.3. All analyses used two-tailed
tests of significance. First, univariate analysis was used to
compare TSE regular performers versus non-regular per-
formers based on sociodemographic, medical, knowl-
edge, HBM, and psychological factors. Independent
variables that were significant at p < 0.05 (T-test, Chi
square test) were then simultaneously entered into a mul-
tiple logistic regression model. Although the individual
was the unit of analysis in this study, the familial nature
of the cohort raised concerns regarding the assumption of
observation independence. Therefore, all analyses that
involved statistical testing (e.g. chi-square or t tests, logis-
tic models) were conducted with a program that
accounted for possible clustering within families (SASHereditary Cancer in Clinical Practice 2009, 7:11 http://www.hccpjournal.com/content/7/1/11
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Proc Surveyfreq, Proc Surveymeans, Proc Surveylogistic;
SAS Institute, 2003). These procedures use the Taylor lin-
earization method to estimate sampling errors of estima-
tors based on potential clustering of responses between
family members. Respondents with missing values for rel-
evant variables were excluded from analyses.
Results
Respondent Characteristics
The majority of respondents were white, ≥ age 35, well-
educated, and married (Table 1). Seventy-four men were
first-degree, and 22 men were second-degree relatives of a
case. Thirteen men reported having at least one testicular
abnormality (e.g. cryptorchidism, orchitis, epididymitis,
injury to testicle).
Performance of TSE
Of the 99 participants who met inclusion criteria for this
sub-study, forty-six percent reported performing TSE six or
more times in the previous year, while 51% reported per-
forming TSE less than 6 times; the remaining 3% did not
respond to this question.
Individual Factors Associated with Regular Performance of 
TSE
Demographic and medical factors positively-correlated (p
< 0.05) with regular performance of TSE were older age (>
35), being a first-degree relative of a family member with
testicular cancer, and having a physician recommend TSE
(Table 1). Additionally, having greater TC knowledge, per-
ceiving greater benefits and fewer barriers related to per-
forming TSE, having higher levels of cancer worry, and
intrusive thoughts related to testicular cancer were associ-
ated with regular performance of TSE (Table 2).
Factors not significantly associated with regular perform-
ance of TSE included marital status, education, having a
prior testicular abnormality, perceived TC susceptibility,
Table 1: Demographic and Medical Characteristics of Unaffected Men from Multiple-Case Testicular Cancer Familiesa
Factor Total
(n = 96)b, c




< 35 28.2 (28) 45.7 (21) 14.0 (7) < 0.001
> 35 68.7 (68) 54.3 (25) 86.0 (43)
Marital Status (%; n)
Divorced/Single/Widowed/Unknown 33.3 (33) 39.1 (18) 30.0 (15) 0.38
Married 66.6 (63) 60.1 (28) 70.0 (35)
Race (%; n)
White 92.0 (91) 93.5 (43) 96.0 (48) 0.14
Other 4.0 (4) 6.5 (3) 2.0 (1)
Education (%; n)
<=high school 16.2 (16) 17.4 (8) 16.0 (8) 0.97
Some college/college graduate 47.5 (47) 50.0 (23) 48.0 (24)
Post graduate 32.3 (32) 32.6 (15) 34.0 (17)
Relation to Case (%; n)
First-Degree Relative 74.7 (74) 91.3 (42) 64.0 (32) < 0.01
Second-Degree Relative 22.2 (22) 8.7 (4) 36.0 (18)
Prior history of TC abnormality 
(cryptorchidism, orchitis, epididymitis, or 
injury to testicle) (%; n)
Yes 13.1 (13) 15.2 (7) 12.0 (6) 0.68
No 82.8 (82) 84.8 (39) 86.0 (43)
Physician Rec. (Cue to Action) (%; n)
Yes 40.4 (40) 69.6 (32) 16.0 (8) < 0.001
No 56.6 (56) 30.4 (14) 84.0 (42)
aFor dichotomous variables, X2 test of heterogeneity was used to compare groups using the Taylor Linearization method to adjust for possible 
familiar clustering; bThree subjects did not respond to the question about TSE and thus were not included in the bivariate analysis; cPercentages may 
not total to 100 due to missing data; dRegularly performed TSE = those reporting ≥ 6 TSEs in the previous year; eDid not regularly perform TSE = 
those reporting < 6 TSEs in the previous yearHereditary Cancer in Clinical Practice 2009, 7:11 http://www.hccpjournal.com/content/7/1/11
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Health Locus of Control (internal, powerful others, or
chance), and having avoidant thoughts.
Multiple logistic regression analyses incorporating the
variables above that were significant in the univariate
analyses were conducted both with (Proc Survey Logistic
Regression) and without adjusting for familial clustering,
with similar results for both methods. The results adjust-
ing for familial clustering are presented in Table 3. The
variables that remained significantly associated (p < .05)
with regular performance of TSE were physician recom-
mendation for performing TSE (OR = 6.6, 95% CI 2.0,
21.1) and having higher levels of cancer worry about TC
(OR = 1.6, 95% CI 1.1, 2.3).
Discussion
Forty six percent of unaffected, at-risk men from multiple-
case TC families in our sample reported regular perform-
ance of TSE. The two factors significantly associated with
regular performance of TSE were physician recommenda-
tion and higher levels of TC cancer worry.
In a 2005 review of TSE practices that included 6 studies
of U.S. men ≥ age 18 [39], the percent of men practicing
TSE on a monthly basis ranged from 6 to 36% Our TSE
rates are not directly comparable to those data, which
defined regular performance of TSE as once a month,
since we used a broader inclusion for our regular per-
former category of 6 times a year or more. This may
explain the higher proportion of men in our sample that
were defined as regular performers of TSE (46%).
With respect to the HBM variables assessed in the current
study, only Cues to Action (i.e. physician recommenda-
tion for TSE), remained a statistically significant predictor
of TSE behavior in multivariate analysis. The importance
of physician recommendation on TSE practice was strik-
ing, with men who reported a physician recommendation
Table 2: Knowledge, Health Belief and Psychosocial Characteristics of Unaffected Men from Multiple-Case Testicular Cancer 
Familiesa
Factor Total
(n = 96)b, c (X+SE)
Regularly Performed TSEb, c (n = 
46) (X+SE)
Did Not Regularly Perform TSEb, d (n 
= 50) (X+SE)
P-value*
Testicular Cancer Knowledge 4.2 (0.3) 5.0 (0.4) 3.5 (0.4) 0.02
Perceived Benefits 24.9 (0.4) 26.4 (0.6) 23.5 (0.5) < 0.01
Perceived Barriers 19.0 (0.5) 17.2 (0.5) 20.5 (0.5) < 0.001
Perceived Severity 
(impact of TC on life)
3.3 (0.1) 3.4 (0.2) 3.2 (0.2) 0.47
Perceived Severity 
(pain and suffering from TC)
3.3 (0.1) 3.3 (0.2) 3.4 (0.1) 0.52
Perceived Severity 
(chance of survival from TC)
2.6 (0.2) 2.5 (0.3) 2.7 (0.3) 0.50
Perceived Susceptibility 8.5 (0.2) 8.9 (0.3) 8.1 (0.3) 0.06
Internal Health Locus of Control 25.2 (0.5) 26.0 (0.7) 24.6 (0.6) 0.13
Powerful Others Health Locus of 
Control
18.9 (0.3) 18.8 (0.5) 19.0 (0.6) 0.84
Chance Health Locus of Control 17.8 (0.4) 17.1 (0.7) 18.4 (0.6) 0.19
Cancer Worry 5.7 (0.3) 6.5 (0.4) 5.0 (0.2) 2
Intrusion 2.1 (0.5) 3.2 (0.9) 1.0 (0.4) 0.03
Avoidance 3.4 (0.7) 4.6 (1.3) 2.2 (0.6) 0.09
aFor continuous variables, independent samples t-test used to compare groups using the Taylor Linearization method to adjust for possible familiar 
clustering; bThree subjects did not respond to the question about practice of TSE and thus were not included in the bivariate analysis; cRegularly 
performed TSE = those reporting ≥ 6 TSEs in the previous year; dDid not regularly perform TSE = those reporting < 6 TSEs in the previous yearHereditary Cancer in Clinical Practice 2009, 7:11 http://www.hccpjournal.com/content/7/1/11
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for TSE having at least six times higher odds of performing
regular TSE compared with those who reported no such
recommendation. This provides yet another example
[33,40,41] of how potent an influence the physician can
be with regard to cancer prevention behavior in patients,
and underscores the importance of physicians including
such recommendations in the course of ongoing health
care discussions. Due to the lack of a strong evidence base
to support the belief that TSE is associated with improved
TC-related survival among those who practice it, and the
remarkable therapeutic successes in managing TC patients
even with far-advanced disease, it is unlikely that there
ever will be a clinical trial testing this question. In this era
of evidence-based medical practice, it is difficult for health
care providers to insist that at-risk men adopt TSE practice,
although common sense and logic suggest that a TC
detected by TSE rather than symptoms should be more
amenable to treatment regimens that do not include
chemotherapy, or permit less intense or shorter chemo-
therapy regimens. This rationale is not unlike recommen-
dations for both BSE, CA-125 testing, and transvaginal
ultrasound recommendations for women at increased risk
for hereditary breast and ovarian cancer [42]. Given that
TC is a disease which affects young men during the most
productive period of their lives, there is potential for real
economic and psychosocial benefit in attempting to min-
imize treatment-associated costs and morbidity.
Two previous studies of the HBM and TSE showed that
perceived benefits and barriers were associated with TSE,
as did our data [19,29]. In our study, perceived cancer sus-
ceptibility was not associated with TSE. Although one pre-
vious study examining the relationship between TSE and
perceived susceptibility found a significant association,
there were only 12 men in the entire study who were con-
sidered to be "practicers" of TSE (i.e. reported practicing
TSE > 4 times a year) [19,29]. A larger study of TSE behav-
iors using multivariate analyses failed to replicate this
finding [29]. Perceived severity of TGCT was not a signifi-
cant predictor of PSA testing. This finding is similar to two
previous studies of TSE that used the HBM as a theoretical
framework [19,29]. Previous cancer screening research for
a variety of sites has also found perceived susceptibility of
little predictive value with regard to screening behaviors,
possibly due to the almost universally held belief that can-
cer is a severe disease, regardless of type [43-48]. In our
study, none of the HBM factors significant in bivariate
analyses remained so when they were considered in a
multivariate model which included physician recommen-
dation. This result is consistent with many previous stud-
ies of cancer screening behaviors.
To our knowledge only one other study has examined
HBM with respect to TSE using multivariate analysis.
Overall, it appears that the HBM does not adequately
explain TSE behavior. Similar to our study, HBM variables
accounted for only a small proportion of the variance in
TSE behavior (21%) [29]. As discussed below, cancer-
related worry was the main psychosocial predictor of TSE
behavior in our study and may lend some support to the
commonly-raised concern regarding the HBM and other
cognitive models of health behavior, namely that they do
not include affective variables as behavior predictors [30].
Cancer-related worry was the other major factor associ-
ated with TSE practice patterns in our study. From a theo-
retical perspective, several relationships between cancer
worry and cancer prevention behaviors have been pro-
Table 3: Logistic Regression Model of Predictors of Testicular Self-examination among Unaffected Men from Multiple-Case Testicular 
Cancer Families (n = 91)
Factor Odds Ratio (95% Confidence Interval)
Age > 35 0.4 (0.1, 1.3)
FDR of Case 2.2 (0.7, 8.0)
Physician Recommendation for TC 6.6 (2.0, 21.1)*
Testicular Cancer Knowledge 1.2 (0.84, 1.6)
Perceived Benefits 1.1 (0.9, 1.4)
Perceived Barriers 0.8 (0.6, 1.0)
Cancer Worry 1.6 (1.1, 2.3)*
Intrusion 1.0 (0.9, 1.1)
*significant at p < .05Hereditary Cancer in Clinical Practice 2009, 7:11 http://www.hccpjournal.com/content/7/1/11
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posed. Some models posit that worry may serve as a facil-
itator to cancer screening behavior, others postulate worry
acts a barrier, and some propose a curvilinear relationship
between cancer worry and preventive behaviors, whereby
worry is a facilitator to a certain level after which it
becomes a barrier [49]. The HBM, which was the theoret-
ical basis of the present study, has been used to support
the role of worry as both a barrier and facilitator for cancer
screening behavior [49]. In our sample, it appears that
cancer worry motivates individuals to practice TSE, since
those with higher levels of cancer worry were also more
likely to perform TSE. However, the directionality of this
relationship can only be established in the context of a
prospective study; our data are cross-sectional. Studies in
other high-risk populations provide some evidence that
cancer worry may in fact precede screening behavior. In a
review of the relationship between cancer worry and
mammography screening among high-risk women, four
of five prospective studies indicated that higher levels of
cancer worry were associated with greater rates mammog-
raphy screening and breast self-examination [49]. How-
ever, no similar prospective studies of high-risk men are
available. One cross-sectional study of prostate cancer
screening among a sample of men at increased risk of
hereditary prostate cancer found a negative relationship
between cancer worry and screening behavior [50].
It is noteworthy that we observed no statistically signifi-
cant differences in TSE practices between men with and
without a prior history of a testicular abnormality. A per-
sonal history of cryptorchidism can increase the risk of TC
up to 11-fold [51]. Of the 13 men reporting a testicular
abnormality in our series, 29% (n = 4) reported a history
of cryptorchidism (data not shown). In a study by Blesch
and colleagues, none of the 5 men with a history of cryp-
torchidism, reported regularly practicing TSE [19]. While
this finding may reflect the small number of men with this
particular risk factor and the associated lack of statistical
power to detect a difference in that study, it is possible
that men may be unaware that testicular maldescent is
among the most strongly-established TC risk factors.
However, no study to date has focused specifically on the
levels of awareness/knowledge of cryptorchidism as a risk
factor for TC or as a multivariate predictor of TSE behav-
ior.
In multivariate analyses, men age = 35 and those who
were first-degree relatives of a TC case were no more likely
to perform TSE than were older men or those whose
affected family member was a more distant relative. In the
2005 review mentioned above [27], only 12–25% of par-
ticipants in U.S. studies were aware of the age group most
affected by TC. In the study by Blesch and colleagues [19],
men with a family history of TC were significantly more
likely to perceive greater benefits to TSE. However, the
study did not assess the impact on actual TSE behavior.
Taken together, the non-differential rates of TSE between
men in younger and older age groups, men who are first
versus second-degree relatives of a TC case, and men with
a prior testicular abnormality compared with those with-
out, suggest a lack of awareness on the part of unaffected
family members regarding the additional risk conferred
by having these characteristics. It is also possible that men
recognize the implications of these characteristics, but
they are not sufficiently concerned by this information to
motivate screening behavior.
To our knowledge, this is the first study to examine TSE
behaviors among unaffected men from multiple-case tes-
ticular cancer families. While the results provide impor-
tant information about current rates and correlates of TSE
in this high-risk group, they should be interpreted with
caution due to certain limitations of our study. A goal of
our study was to evaluate the utility of HBM in under-
standing TSE behavior. Ideally, use of an analytic tech-
nique such as structural equation modeling would allow
us to definitively test the utility of HBM in predicting TSE
behavior. However, our study was designed as a pilot
study of the utility of HBM and it did not have a sample
size sufficient to reach definitive conclusions. It is possible
that the HBM did not adequately capture those factors
that were important in TSE behavior. For example, one of
the major criticism of HBM and other cognitive models of
health behavior is the lack of inclusion of affective varia-
bles (e.g. distress) [30]. To address this issue, we included
scales for both cancer worry and cancer distress. Addition-
ally, we included demographic and SES variables that may
also impact screening behavior. Finally, in a study that
compared the HBM to the Theory of Planned Behavior,
the quality of the models was very similar. The TPB
explained 22%of the variance in behavior versus 21% by
the HBM, suggesting that applying another theoretical
framework may have yielded similar results [29]. Thus,
based on our review of the literature related to theories of
health behavior and predictors of screening, we feel that
we adequately expanded the HBM to include other factors
associated with TSE behavior. In addition, this was a
cross-sectional study, making it difficult to establish that
the beliefs and psychological factors we identified pre-
ceded the behavior, as hypothesized in the HBM. Addi-
tionally, men volunteering to participate in a study of
familial TC may be more aware of and concerned about
TC. Thus, the rates of TSE may be higher in this study pop-
ulation than men with a similar history not participating
in such a study. Similarly, these men may be more knowl-
edgeable about TC and have differing beliefs and psycho-
logical responses to TC.
As molecular genetic diagnosis improves, family history
of TC will become an increasingly important risk factor onHereditary Cancer in Clinical Practice 2009, 7:11 http://www.hccpjournal.com/content/7/1/11
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which to base decisions for primary, secondary, and terti-
ary prevention of TC. The present study showed that
among men with a family history of TC, those who had
higher levels of cancer worry were more likely to practice
TSE regularly. However, findings also revealed that men at
increased risk of TC due to a positive family history may
be either less knowledgeable about and/or less motivated
to perform TSE even if they are younger, have a prior tes-
ticular abnormality, or are a FDR of a man with TC. Thus,
these are areas in which men may benefit from additional
education and information upon which to base decisions
about TSE practices. Physician recommendation emerged
as the most important predictor of regular performance of
TSE. Despite the absence of proof regarding the efficacy of
TSE, it nonetheless remains prudent to encourage health
care providers to recommend monthly TSE for high-risk
patients, and to instruct their patients in performing this
examination. Given the superficial/accessible location of
the testes, and the existence of non-invasive imaging (tes-
ticular ultrasound) and tumor marker assays, the price
one pays for a false-positive screening examination is
likely to be substantially less than would be the case for
ovarian cancer screening, for example. Finally, providing
at-risk men information regarding accepted TC risk fac-
tors, as a means of deepening their understanding of their
own risk, might help to correct some of the information
deficiencies we identified. Despite the limitations in both
our and other's studies, we have adopted the policy of rec-
ommending monthly TSE as a screening modality for
unaffected bloodline males from multiple-case TC fami-
lies, while clearly informing our patients that this repre-
sents our best clinical judgment rather than an evidence-
based recommendation.
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